T LYMPHOCYTE SENSITIZATION AND SUPPRESSOR T LYMPHOCYTE DEFECT IN PATIENTS LONG AFTER TREATMENT FOR GRAVES’DISEASE

1983 ◽  
Vol 18 (1) ◽  
pp. 61-71 ◽  
Author(s):  
JACQUES HOW ◽  
DUNCAN J. TOPLISS ◽  
CHRISTOPHER STRAKOSCH ◽  
MARK LEWIS ◽  
VAS V. ROW ◽  
...  
1982 ◽  
Vol 101 (3) ◽  
pp. 354-358 ◽  
Author(s):  
Bengt Hallengren ◽  
Arne Forsgren

Abstract. To explore suppressor T lymphocyte function in Graves' disease, studies were performed in one group of patients in the hyperthyroid state and in another group in the euthyroid state after treatment. Peripheral blood lymphocytes were cultured for 1–7 days., Pokeweed mitogen (PWM; 1.25 μg/ml) was added at the initiation of the cultures or after 24 h. The degree of lymphocyte activation was assessed by measurements of the cellular uptake of [3H]thymidine and expressed in counts per minute (cpm). The suppressor lymphocyte function was estimated by a quotient between the maximum cpm values from cultures with and without pre-incubation. For the hyperthyroid group (n = 15) the quotient was 1.00 ± 0.07 (mean ± sem), for the euthyroid patient group (n = 21) 1.12 ± 0.05 and for the healthy control group (n = 21) 1.37 ± 0.08. There was a significant difference between the quotients for the control group and the hyperthyroid (P < 0.01) as well as the euthyroid (P < 0.05) patient group. The quotients for the two groups of patients did not differ significantly. In conclusion, the present study supports the view of a defect in suppressor T lymphocyte function in patients with Graves' disease in the hyperthyroid state and indicates that this defect can persist in the euthyroid state after treatment.


BMJ ◽  
1974 ◽  
Vol 3 (5926) ◽  
pp. 345-345
Author(s):  
H M Chapel ◽  
J R Batchelor

BMJ ◽  
1974 ◽  
Vol 1 (5908) ◽  
pp. 635-636 ◽  
Author(s):  
N R Farid ◽  
R E Munro ◽  
V V Row ◽  
R Volpe

1995 ◽  
Vol 37 (3) ◽  
pp. 219-224 ◽  
Author(s):  
J. L. Blejer ◽  
C. M. Godio ◽  
R Negroni ◽  
M. R. Nejamkis

Paracoccidioidomycosis is an endemic fungal disease widely distributed throughout Latin America. The potent immunosuppressor cyclophosphamide (CY) has been used to modulate host immune response to Paracoccidioides brasiliensis in an experimental model. Inbred male Buffalo/Sim rats weighing 250-300 g were inoculated with 5 x 10(6) P. brasiliensis cells of the yeast phase form by intracardiac route. One group of animals was treated with 20 mg/kg body weight at days +4, +5, +6, +7, +11 and +12 post-infection (pi.), while a control group was infected alone. No mortality was recorded in either group. Treated rats presented: a) a decrease in granuloma size, which contained less fungal cells; b) a lack of specific antibodies up to 35 days pi., and c) a significant increase in the footpad swelling test (DTH) against paracoccidioidin. Splenic cell transfer from CY-treated P. brasiliensis-infected donors to recipients infected alone led to a significant increase in DTH response in the latter versus untreated infected controls. Likewise, in treated infected recipients transferred with untreated infected donor spleen cells, footpad swelling proved greater than in controls. Thus, it would seem that each successive suppressor T lymphocyte subset belonging to the respective cascade may be sensitive to repeated CY doses administered up to 12 days pi.. Alternatively, such CY schedule may induce the appearance of a T cell population capable of amplifying DTH response.


1979 ◽  
Vol 300 (13) ◽  
pp. 700-704 ◽  
Author(s):  
Andrew Saxon ◽  
Ronald H. Stevens ◽  
David W. Golde

Hepatology ◽  
1985 ◽  
Vol 5 (2) ◽  
pp. 192-197 ◽  
Author(s):  
Sandro Vento ◽  
John E. Hegarty ◽  
Alfredo Alberti ◽  
Charles J. O'brien ◽  
Graeme J. M. Alexander ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document